BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, Zhang C, Wang Y, Liu WJ. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev 2021;2021:2074610. [PMID: 34956436 DOI: 10.1155/2021/2074610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Chen M, Wang Z, Fan Q, Lin Z, Tao X, Wu J, Liu Z, Lin R, Zhao C. Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis. Bone Joint Res 2023;12:91-102. [PMID: 36718649 DOI: 10.1302/2046-3758.122.BJR-2022-0269.R1] [Reference Citation Analysis]
2 Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T, Verdile G. Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease. Int J Mol Sci 2022;23. [PMID: 36555450 DOI: 10.3390/ijms232415811] [Reference Citation Analysis]
3 Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, Xu N, Hou K, Hu Z, Chen Y, Chen R. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1015045] [Reference Citation Analysis]
4 Raghav SS, Kumar B, Sethiya NK, Kaul A. A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview. Future Pharmacology 2022;2:511-546. [DOI: 10.3390/futurepharmacol2040032] [Reference Citation Analysis]
5 Hu S, Wang J, Liu E, Zhang X, Xiang J, Li W, Wei P, Zeng J, Zhang Y, Ma X. Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action. Pharmacological Research 2022;185:106481. [DOI: 10.1016/j.phrs.2022.106481] [Reference Citation Analysis]
6 Zamani M, Zarei M, Nikbaf-Shandiz M, Hosseini S, Shiraseb F, Asbaghi O. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis. Front Nutr 2022;9:1013055. [PMID: 36313096 DOI: 10.3389/fnut.2022.1013055] [Reference Citation Analysis]
7 Zhou K, Zi X, Song J, Zhao Q, Liu J, Bao H, Li L. Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease. Molecules 2022;27:6221. [DOI: 10.3390/molecules27196221] [Reference Citation Analysis]
8 Lupo MG, Brilli E, De Vito V, Tarantino G, Sut S, Ferrarese I, Panighel G, Gabbia D, De Martin S, Dall’acqua S, Ferri N. In Vitro and In Vivo Sucrosomial® Berberine Activity on Insulin Resistance. Nutrients 2022;14:3595. [DOI: 10.3390/nu14173595] [Reference Citation Analysis]
9 Djuricic I, Calder PC. Polyunsaturated fatty acids and metabolic health: novel insights. Curr Opin Clin Nutr Metab Care 2022. [PMID: 35943130 DOI: 10.1097/MCO.0000000000000865] [Reference Citation Analysis]
10 Lewis KD, Falk M. Toxicological assessment of dihydroberberine. Food Chem Toxicol 2022;:113301. [PMID: 35868606 DOI: 10.1016/j.fct.2022.113301] [Reference Citation Analysis]
11 Casula M, Catapano AL, Magni P. Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet). Nutrients 2022;14:606. [DOI: 10.3390/nu14030606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]